Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Uprichard Insider Profile
4 Followers
David Uprichard, Director at Cyclacel Pharmaceuticals, holds 25.31K shares in Cyclacel Pharmaceuticals (Ticker: CYCC), holds ― shares in Life Technologies Corp (Ticker: ~LIFE). Most recently, David Uprichard ― shares of Cyclacel Pharmaceuticals on ― for an estimated value of ―.
David Uprichard Cyclacel Pharmaceuticals (CYCC)Director
Cyclacel Pharmaceuticals (CYCC)
Director
Ranked #63,066 out of 78,624 Corporate Insiders
Profitable Transactions
12 out of 52 Profitable Transactions
Average Return
-5.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of David Uprichard's holdings
Insider Roles
Director
Roles that David Uprichard holds in companies
Most Profitable Insider Trade
Stock:
Life Technologies Corp
(~LIFE)
(~LIFE)
Rating:Informative Buy
Date:Feb 04, 2009 - Feb 04, 2010
Return:+31.50%
The most profitable trade made by David Uprichard
David Uprichard's Trading History
Cyclacel Pharmaceuticals
―
Director
―
$97.43K
Life Technologies Corp
Feb 04, 2014
―
Uninformative Sell
223.06K
―
List of latest transactions for each holding click on a transaction to see David Uprichard's performance on stock
You May Also Like
David Uprichard insider profile FAQ
What is the percentage of profitable transactions made by David Uprichard?
The percentage of profitable transactions made by David Uprichard is 23%.
What is the average return per transaction made by David Uprichard?
The average return per transaction made by David Uprichard is -5.50%.
What stocks does David Uprichard hold?
David Uprichard holds: CYCC, ~LIFE stocks.
What was David Uprichard’s latest transaction?
David Uprichard latest transaction was an Uninformative Buy of ―.
What was David Uprichard's most profitable transaction?
David Uprichard’s most profitable transaction was an Informative Buy of ~LIFE stock on February 4, 2009. The return on the trade was 31.50%.
What is David Uprichard's role in Cyclacel Pharmaceuticals?
David Uprichard's role in Cyclacel Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.